Richeldi, L., Kreuter, M., & Quaresma, M. (2018). Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: Results from the TOMORROW trial and its open-label extension. Thorax, 73(6), . https://doi.org/10.1136/thoraxjnl-2016-209701
Chicago-Zitierstil (17. Ausg.)Richeldi, Luca, Michael Kreuter, und Manuel Quaresma. "Long-term Treatment of Patients with Idiopathic Pulmonary Fibrosis with Nintedanib: Results from the TOMORROW Trial and Its Open-label Extension." Thorax 73, no. 6 (2018). https://doi.org/10.1136/thoraxjnl-2016-209701.
MLA-Zitierstil (9. Ausg.)Richeldi, Luca, et al. "Long-term Treatment of Patients with Idiopathic Pulmonary Fibrosis with Nintedanib: Results from the TOMORROW Trial and Its Open-label Extension." Thorax, vol. 73, no. 6, 2018, https://doi.org/10.1136/thoraxjnl-2016-209701.